Holen Sie sich die Stockscreener-App
205.29
0.33%
-0.67
Schlusskurs vom Vortag:
$205.96
Offen:
$206.85
24-Stunden-Volumen:
2.09M
Relative Volume:
1.33
Marktkapitalisierung:
$9.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.14%
1M Leistung:
-3.98%
6M Leistung:
+21.17%
1J Leistung:
+37.21%
1-Tages-Spanne:
$204.14
$206.99
1-Wochen-Bereich:
$204.14
$212.62
52-Wochen-Spanne:
$149.09
$217.12
Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
Ishares Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
205.29 | 9.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
377.99 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
769.64 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.10 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
288.99 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
749.58 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
SPDR S&P Biotech ETF (XBI) stock price, news, quote and history - uk.finance.yahoo.com
State Street SPDR S&P Biotech ETF (XBI) stock price, news, quote and history - Yahoo Finance Singapore
IBB Top Holdings List & Exposure (iShares Biotechnology ETF) - MarketBeat
Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK - The Motley Fool
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - ca.finance.yahoo.com
XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration - The Motley Fool
iShares Biotechnology ETF (IBB) stock price, news, quote and history - Yahoo Finance UK
iShares Biotechnology ETF (IBB) Short Interest & Short Float | Updated Sep 2026 $IBB - MarketBeat
Healthcare Stocks Slipped As Biotech Took The Bigger Hit - Finimize
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH - The Motley Fool
Biotech Week Ahead: XLV Beats The Market — Here Are The Stocks, Readouts And Events To Watch Next - tradingview.com
iShares Biotechnology ETF rStock (RIBB) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
Should You Invest in the VanEck Biotech ETF (BBH)? - finance.yahoo.com
6 Best Healthcare Funds and ETFs to Buy Now | Investing - US News Money
iShares Biotechnology ETF (IBB) Stock Price, Chart & News Today - CoinGecko
Sector Update: Healthcare Stocks Decline Late Afternoon - Moomoo
KATT ETF Price and Chart — CBOE:KATT - TradingView
7 Best Biotech ETFs to Buy Now | Investing - US News Money
Biotech ETF IBB outperformed S&P 500 by 22 poin... - Pluang
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
iShares Biotechnology ETF (NASDAQ: IBB) Share Price, IBB Stock News, IBB Share Price & Updates - Kalkine
Sector Update: Healthcare Stocks Decline Friday Afternoon - Moomoo
Biotech Is Popping. No One Seems to Care. - The Daily Upside
The Next Biotech Boom May Be Cancer Vaccines. Watch These ETFsModerna (NASDAQ:MRNA) - Benzinga
IBB/HKD Price: Convert iShares Biotechnology ETF to Hong Kong Dollar - Crypto.com
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? - The Motley Fool
IBB PE Ratio & Valuation, Is IBB Overvalued - Intellectia AI
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? - The Motley Fool
Biotech Is Booming, But These 2 Stocks Missed the MemoModerna (NASDAQ:MRNA), iShares Biotechnology ETF - Benzinga
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In FocusMerck & Co (NYSE:MRK) - Benzinga
Ishares Biotech ETF up 3.2%, State Street Spd - Moomoo
Wagner Wealth Management, Corp's iShares Biotechnology ETF(IBB) Holding History - GuruFocus
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):